| Execution period | 12 months |
|---|
NSE filing, NSE: LEMONTREE. Summary written from the filing by ALFA Finder's alert engine.
Lemon Tree Hotels Ltd: key numbers
- Share price
- ₹119.54
- Market cap
- ₹9,471 Cr
- Revenue (annual)
- ₹1,444 Cr
- Net profit (annual)
- ₹227.1 Cr
- P/E (TTM)
- 36.9×Sector 47.2×
- Promoter holding
- 22.32%+0.00% QoQ
- FII holding
- 18.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lemon Tree Hotels Ltd
All →Lemon Tree Hotels Earnings Call Transcript: Key Takeaways
Best-ever Q2: revenue ₹363.8 Cr (+18%), PAT ₹79.8 Cr (+90%), but PAT includes ~₹22 Cr net non-cash exceptional gain; corporate demand still muted.
Lemon Tree Hotels Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹363.8 Cr (+18%), net EBITDA ₹162.2 Cr (+22%, 44.6% margin), PAT ₹79.8 Cr (+90%). Best-ever Q2; asset-light network expansion continues.
Lemon Tree Hotels Q2 FY27 Results: Net Profit ₹79.8 Cr, Up 90.5% YoY
Lemon Tree Hotels Ltd reported revenue from operations of ₹361.4 Cr (+18.0% YoY) and net profit of ₹79.8 Cr (+90.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹79.8 Cr · +90.5% YoY
Lemon Tree Hotels Capacity Expansion
Lemon Tree Hotels opened its 44-room Lemon Tree Resort in Pavagadh, Gujarat, managed by its wholly owned subsidiary Carnation Hotels. The launch marks the group's 11th operational resort.
- hotel rooms
- 44.0 rooms
Lemon Tree Hotels Business Update
Lemon Tree Hotels rebranded three existing hotels in Bengaluru and Hyderabad effective 1 November 2026 following renovation. The changes move two properties to the upscale Lemon Tree Premier brand and one to Lemon Tree Hotel, with no new capacity or monetary amount disclosed.
Lemon Tree Hotels Board Meeting Date
Lemon Tree Hotels announced a board meeting on November 5, 2026, to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Other board meeting outcome announcements
All →Ennature Bio Pharma Board Meeting Outcome
Ennature Bio Pharma's board approved adoption of new Articles of Association to align with SCRA Rules 1957 and group governance. The change is subject to shareholder approval.
Shri Keshav Cements & Infra Board Meeting Outcome
Shri Keshav Cements' board approved un-audited financial and segment-wise revenue results for the quarter and half-year ended 30 September 2026. No other material decisions were transacted.
Balmer Lawrie Investments Board Meeting Outcome
Balmer Lawrie Investments appointed M/s. K. K. Chanani & Associates as Statutory Auditor for FY 2026-27 under Section 139(5), per a C&AG letter. The appointment is effective from 10 November 2026.
- Execution
- FY 2026-27
Jiwanram Sheoduttrai Industries Board Meeting Outcome
Jiwanram Sheoduttrai's board approved convening its 29th AGM on 30 November 2026 and re-appointing a retiring non-executive director. The board also approved the FY2025-26 Board's Report.
Finolex Cables Board Meeting Outcome
Finolex Cables' board approved amending its insider trading code of conduct on 7 November 2026. Amended code was filed under PIT Regulation 8(2).
Chatterbox Technologies Board Meeting Outcome
Chatterbox's board approved a Rs. 7 crore related-party ceiling with its UAE subsidiary and a vendor change for IPO funds. Monitoring agency and deviation reports were also noted.